Xue Y - Search Results

1

Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.

Ji L, Su Q, Feng B, Shan Z, Hu R, Xing X, Xue Y, Yang T, Hua Y. Ji L, et al. Among authors: xue y. J Diabetes. 2017 May;9(5):495-501. doi: 10.1111/1753-0407.12434. Epub 2016 Aug 21. J Diabetes. 2017. PMID: 27249791 Clinical Trial.

2

Inadequate glycaemic control and antidiabetic therapy among inpatients with type 2 diabetes in Guangdong Province of China.

Bi Y, Yan JH, Liao ZH, Li YB, Zeng LY, Tang KX, Xue YM, Yang HZ, Li L, Cai DH, Wu G, Zhang F, Lin SD, Xiao ZH, Zhu DL, Weng JP. Bi Y, et al. Among authors: xue ym. Chin Med J (Engl). 2008 Apr 20;121(8):677-81. Chin Med J (Engl). 2008. PMID: 18701017

3

Insulin pump therapy guidelines for China (July 2010).

Mu Y, Yin S; Chinese Medical Practitioners Association, Endocrinology and Metabolism Branch, Chinese Society of Endocrinology, Chinese Diabetes Society. Mu Y, et al. J Diabetes. 2012 Jun;4(2):127-39. doi: 10.1111/j.1753-0407.2011.00174.x. J Diabetes. 2012. PMID: 22107806 No abstract available.

4

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.

Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; SPREAD-DIMCAD Investigators. Hong J, et al. Diabetes Care. 2013 May;36(5):1304-11. doi: 10.2337/dc12-0719. Epub 2012 Dec 10. Diabetes Care. 2013. PMID: 23230096 Free PMC article. Clinical Trial.

5

Efficacy and safety of acarbose chewable tablet in patients with type 2 diabetes: a multicentre, randomized, double-blinded, double-dummy positive controlled trial.

Wu QL, Liu YP, Lu JM, Wang CJ, Yang T, Dong JX, Li CJ, Ma JH, Xue YM, Sun RH, Wei D, Tian HM. Wu QL, et al. J Evid Based Med. 2012 Aug;5(3):134-8. doi: 10.1111/j.1756-5391.2012.01188.x. J Evid Based Med. 2012. PMID: 23672220 Clinical Trial.

6

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.

Roden M, Weng J, Eilbracht J, Delafont B, Kim G, Woerle HJ, Broedl UC; EMPA-REG MONO trial investigators. Roden M, et al. Lancet Diabetes Endocrinol. 2013 Nov;1(3):208-19. doi: 10.1016/S2213-8587(13)70084-6. Epub 2013 Sep 9. Lancet Diabetes Endocrinol. 2013. PMID: 24622369 Clinical Trial.

7

Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial.

Cai XL, Chen YL, Zhao JJ, Shan ZY, Qiu MC, Li CJ, Gu W, Tian HM, Yang HZ, Xue YM, Yang JK, Hong TP, Ji LN. Cai XL, et al. Chin Med J (Engl). 2015 May 20;128(10):1279-87. doi: 10.4103/0366-6999.156735. Chin Med J (Engl). 2015. PMID: 25963345 Free PMC article. Clinical Trial.

8

Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes.

Cao Y, Gao F, Zhang Q, Xu L, Wan Q, Li W, Li J, Wang L, Xue Y. Cao Y, et al. Among authors: xue y. J Diabetes. 2017 May;9(5):502-509. doi: 10.1111/1753-0407.12436. Epub 2016 Sep 22. J Diabetes. 2017. PMID: 27255431 Clinical Trial.

9

Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin.

Chen X, Xu Y, Zhang J, Shao S, Duan Y, Liu P, Shen L, Zhang J, Zeng J, Lin M, Zhao S, Ma J, Zhao T, Hu J, Liao Y, Chen X, Hu S, Xue Y, Zeng Z, He W, Liu Z, Li W, Liu L, Yin P, Yu X. Chen X, et al. Among authors: xue y. Endocr Pract. 2021 Aug;27(8):790-797. doi: 10.1016/j.eprac.2021.03.015. Epub 2021 Apr 6. Endocr Pract. 2021. PMID: 33831552 Clinical Trial.

10

Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III).

Li L, Yang T, Xue Y, Ruan P, Du J, Li Y, Zhang X, Cui N, Yang W. Li L, et al. Among authors: xue y. Adv Ther. 2022 Jan;39(1):421-429. doi: 10.1007/s12325-021-01932-2. Epub 2021 Nov 10. Adv Ther. 2022. PMID: 34757600 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,488 results

Search Page